Medical News

RSS

Championing innovation: Bedfont® Scientific CTO shortlisted for Technology Leader of the Year

Scott Deamer-Smith, Chief Technology Officer (CTO) at Bedfont® Scientific Limited, has been recognized for his outstanding contribution to innovation and technology.

From Bedfont® Scientific Ltd 26 Mar 2026

Spear Bio introduces new ultra-sensitive neurodegenerative assays and expands direct access at AD/PD 2026

Spear Bio, an innovator in ultrasensitive protein biomarker detection, showcased three new SPEAR UltraDetect™ immunoassays—brain-derived p-Tau 217 (BD-pTau 217), α-synuclein (α-syn) and phospho-Ser129-α-synuclein (pS129-α-syn)—at the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2026) last week.

From Spear Bio 26 Mar 2026

Proposed policy solutions for the worldwide rise in chronic diseases

Chronic diseases including cancer, diabetes, neurocognitive disorders and infertility are rising globally, with health-harming products such as fossil fuels, tobacco, ultra‑processed foods, toxic chemicals, plastics and alcohol being major contributors, say the authors of a new paper published in New England Journal of Medicine (NEJM). The authors include proposed solutions, including policy safeguards and a stronger research focus on the risks to health connected with corporate activity.

26 Mar 2026

Microtubules unveiled as active enzyme regulators

Microtubules, the dynamic filaments that form the cell's internal scaffolding, have long been viewed as mere passive structural supports. But a new study reveals they play a far more active signaling role. The findings, published in Science Advances, demonstrate that microtubules are in fact regulators of enzymatic reactions through reshaping the geometry of the enzyme's substrate proteins attached to them and controlling when key events occur to conduct cell division.

26 Mar 2026

Scientists discover how brain development programs fuel pediatric tumors

A team of researchers at Baylor College of Medicine, St. Jude Children's Research Hospital, Texas Children's Hospital, and collaborating institutions reveals in the journal Nature a novel mechanism that drives the development of pediatric supratentorial ependymoma (EPN), the third most common pediatric brain tumor. The findings suggest potential new approaches to treat these aggressive and chemo-resistant tumors.

26 Mar 2026

The molecular mechanism that turns cool temps into nerve signals

When you reach into a bucket of ice, open your front door on a snowy day, or feel the tingle of menthol toothpaste, a protein in your nerve cells called TRPM8 springs into action, opening like a tiny gate to send a "cold" signal to your brain.

26 Mar 2026

DICP scientists develop high-efficiency CO2 hydrogenation catalyst

Formate is a key chemical building block widely used across industries. Converting carbon dioxide (CO2) into formate via hydrogenation provides a promising approach to transform a greenhouse gas into a high-value chemical. However, while heterogeneous catalysts based on non-precious metals have been explored for this reaction, their practical application has been limited by low intrinsic reactivity.

26 Mar 2026

The lifelong cardiovascular impact of placental abruption

Rutgers Health research shows the risk of developing early cardiovascular disease or dying from cardiovascular disease by the age of 28 was 4.6 times higher among people born to mothers who had a placental abruption during their pregnancy.

26 Mar 2026

Analyzing the disparity between youth and adult HPV uptake

Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and can cause various types of cancer. Prophylactic HPV vaccination is highly effective and has been recommended in Switzerland since 2007 for girls and young women aged 11 to 26 – and since 2015 also for boys and young men. Catch-up vaccination is also available for women up to the age of 45.

26 Mar 2026

Study links androgens to aggressive childhood brain tumor growth

An international team led by researchers at Baylor College of Medicine, Texas Children's Hospital, McGill University and University of Pittsburgh School of Medicine has discovered what drives the growth of a lethal pediatric brain tumor called Posterior Fossa Type A (PFA) ependymoma.

25 Mar 2026

New brain atlas reveals how the human neocortex forms over time

In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment and the brain later in life, investigators at Johns Hopkins Medicine and colleagues throughout the world have been mapping the molecular construction of the human brain.

25 Mar 2026

New tool aims to support the delivery of whole-person care in everyday clinical practice

As whole-person care accelerates across the U.S. health care system, clinicians face a persistent and consequential gap: the lifestyle and upstream health factors that drive chronic disease remain largely unmeasured, undocumented, and uncompensated in health care data systems.

25 Mar 2026

New guidance aims to standardize tumor mutational burden in cancer

Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related adverse events remain a major concern.

25 Mar 2026

Childhood ADHD medication shows protective effect against future psychosis

A major new study, led by scientists at University College Dublin and the University of Edinburgh and funded by the St John of God Research Foundation, has found that commonly prescribed attention deficit hyperactivity disorder (ADHD) medication in childhood may lower the long‑term risk of developing serious psychotic disorders, including schizophrenia.

25 Mar 2026

Study links social media addiction to worse student mental health and points to family as a key buffer

A study of 627 Saudi university students found that higher social media addiction was associated with more anxiety and depression, while family environment fully mediated those links in the statistical model. The findings suggest that supportive family relationships may help buffer the mental health burden associated with problematic social media use, although the cross-sectional design does not establish causation.

25 Mar 2026

Community parenting programs improve family wellbeing and reduce inequalities

Evidence-based parenting programs delivered through community organisations can support family wellbeing and should be considered as part of wider strategies to reduce health inequalities, a landmark UCL study has found.

25 Mar 2026

Estradiol patches as effective as injections for locally advanced prostate cancer

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL (University College London) researchers.

25 Mar 2026

Immunotherapy plus chemotherapy improves outcomes in stage III dMMR colon cancer

A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with stage III colon cancer with deficient deoxyribonucleic acid (DNA) mismatch repair (dMMR) had significantly better outcomes when the immunotherapy drug atezolizumab (Tecentriq®) was added to standard chemotherapy after surgery.

25 Mar 2026

Breast cancer patients may avoid lymphedema with radiotherapy approach

Patients with breast cancer may be able to avoid lymphedema, which can occur after surgery to remove lymph nodes in the armpit (the axilla), by having radiotherapy instead.

25 Mar 2026

Stroke may trigger younger brain patterns in unaffected regions

In a new study published in The Lancet Digital Health, scientists at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) have discovered that the brains of people who experience severe physical impairment after a stroke may reorganize themselves in unexpected ways, showing signs of "younger" brain structure in undamaged regions as they adapt to injury.

25 Mar 2026